Skip to main content
Log in

A multicenter randomized controlled clinical trial of bovine surfactant for prevention of respiratory distress syndrome

  • Treatment Of Respiratory Distress Syndrome
  • Published:
Lung Aims and scope Submit manuscript

Abstract

Treatment with bovine surfactant (SF-RI 1) was shown to be efficacious in improving pulmonary function and in increasing survival rate without BPD in very premature infants. Surfactant therapy did not affect the risk of major complications of prematurity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hallman M, Merritt TA, Jarvenpaa AL, Boynton B, Mannino F, Gluck L, Moore T, Edwards D (1985) Exogenous human surfactant for treatment of severe respiratory distress syndrome: a randomized prospective clinical trial. J Pediatr 106:963–969

    Article  PubMed  CAS  Google Scholar 

  2. Merritt TA, Hallman M, Bloom BT, Berry C, Benirschke K, Sahn D, Key T, Edwards D, Jarvenpaa AL, Pohjavuori M, Kankaanpaa K, Kunnas M, Paatero H, Rapola J, Jaaskelainen J (1986) Prophylactic treatment of very premature infants with human surfactant. N Engl J Med 315:785–790

    Article  PubMed  CAS  Google Scholar 

  3. Enhorning G, Shennan A, Possmayer F, Dunn M, Chen CP, Milligan J (1985) Prevention of neonatal respiratory distress syndrome by tracheal installation of surfactant: a randomized clinical trial. Pediatrics 76:145–153

    PubMed  CAS  Google Scholar 

  4. Kwong MS, Egan EA, Notter RH, Shapiro DL (1985) Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics 76:585–592

    PubMed  CAS  Google Scholar 

  5. Gitlin JD, Soll RF, Parad RB, Horbar JD, Feldmann HA, Lucey JF, Taeusch HW (1987) Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Pediatrics 79:31–37

    PubMed  CAS  Google Scholar 

  6. Raju TNK, Vidyasagar D, Bhat R, Sobel D, McCulloch KM, Anderson M, Maeta H, Levy PS, Furner S (1987) Double-blind controlled trial of single-dose treatment with bovine surfactant in severe hyaline membrane disease. Lancet I:651–656

    Article  Google Scholar 

  7. Kendig JW, Notter RH, Cox C, Aschner JL, Benn S, Bernstein RM, Hendricks-Munoz K, Maniscalco WM, Metlay LA, Phelps DL, Sinkin RA, Wood BP, Shapiro DL (1988) Surfactant replacement therapy at birth: Final analysis of a clinical trial and comparisons with similar trials. Pediatrics 82:756–762

    PubMed  CAS  Google Scholar 

  8. Horbar JD, Soll RF, Sutherland JM, Kotagal U, Philip AGS, Kessler DL, Little GA, Edwards WH, Vidyasagar D, Raju TNK, Jobe AH, Ikegami M, Mullett MD, Myerberg DZ, McAufliffe TL, Lucey JF (1989) A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N Engl J Med 320:959–965

    Article  PubMed  CAS  Google Scholar 

  9. Collaborative European Multicenter Study Group (1988) Surfactant replacement therapy for severe neonatal respiratory distress syndrome: an international randomized clinical trial. Pediatrics 82:683–691

    Google Scholar 

  10. Merritt TA, Hallman M (1988) Surfactant replacement. A new era with many challenges for neonatal medicine. Am J Dis Child 142:1333–1339

    PubMed  CAS  Google Scholar 

  11. Disse B, Gortner L, Weller E, Eberhardt H, Ziegler H (1988) Efficacy and standardisation of SF-RI 1: a preparation from bovine lung surfactant. In: Lachmann B, ed. Surfactant replacement therapy in neonatal and adult respiratory distress syndrome. Berlin, Heidelberg, New York: Springer-Verlag, pp 37–41

    Google Scholar 

  12. Gortner L, Pohlandt F, Disse B, Weller E (in press) Effects of tracheal instillation of bovine surfactant (SF-RI 1) in premature lambs. Eur J Pediatr

  13. Gortner L, Pohlandt F, Bartmann P, Disse B (1990) Die Behandlung des Atemnotsyndroms (RDS) sehr kleiner Frühgeborener mit natürlichem Surfactant. Monatsschr Kinderheilk 138:8–12

    CAS  Google Scholar 

  14. Toce SS, Farrell PM, Leavitt LA, Samuels DP, Edwards DK (1984) Clinical and roentgenographic scoring systems for assessing bronchopulmonary dysplasia. Am J Dis Child 138:581–585

    PubMed  CAS  Google Scholar 

  15. Jobe A, Ikegami M (1987) Surfactant for the treatment of respiratory distress syndrome. Am Rev Respir Dis 136:1256–1275

    PubMed  CAS  Google Scholar 

  16. Heicher DA, Kasting DS, Harrod JR (1981) Prospective clinical comparison of two methods for mechanical ventilation of neonates. Rapid rate and short inspiratory time versus slow rate and long inspiratory time. J Pediatr 98:957–961

    Article  PubMed  CAS  Google Scholar 

  17. Shankaran S, Slovis TL, Bedard MP, Poland RL (1982) Sonographic classification of intracranial hemorrhage. A prognostic indicator of mortality, morbidity, and short-term neurologic outcome. J Pediatr 100:469–475

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gortner, L., Bernsau, U., Hellwege, H.H. et al. A multicenter randomized controlled clinical trial of bovine surfactant for prevention of respiratory distress syndrome. Lung 168 (Suppl 1), 864–869 (1990). https://doi.org/10.1007/BF02718221

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02718221

Key words

Navigation